BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28403219)

  • 1. Incidental hepatocellular carcinoma after liver transplantation: Prevalence, histopathological features and prognostic impact.
    Pérez P; Rodríguez-Perálvarez M; Guerrero L; González V; Sánchez R; Centeno M; Poyato A; Briceño J; Sánchez-Frías M; Montero JL; De la Mata M
    PLoS One; 2017; 12(4):e0175010. PubMed ID: 28403219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-up Imaging After Liver Transplantation Should Take Into Consideration Primary Hepatocellular Carcinoma Characteristics.
    Dioguardi Burgio M; Ronot M; Fuks D; Dondero F; Cauchy F; Gaujoux S; Dokmak S; Paradis V; Durand F; Belghiti J; Vilgrain V
    Transplantation; 2015 Aug; 99(8):1613-8. PubMed ID: 25710611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of incidentally detected hepatocellular carcinoma in explanted livers after living donor liver transplantation.
    Rajakannu M; Vij M; Shaikh TMA; Rammohan A; Reddy MS; Rela M
    Indian J Gastroenterol; 2021 Feb; 40(1):30-34. PubMed ID: 33548018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma.
    Rodríguez-Perálvarez M; Tsochatzis E; Naveas MC; Pieri G; García-Caparrós C; O'Beirne J; Poyato-González A; Ferrín-Sánchez G; Montero-Álvarez JL; Patch D; Thorburn D; Briceño J; De la Mata M; Burroughs AK
    J Hepatol; 2013 Dec; 59(6):1193-9. PubMed ID: 23867318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation.
    Zhang Q; Deng YL; Liu C; Huang LH; Shang L; Chen XG; Wang LT; Du JZ; Wang Y; Wang PX; Zhang H; Shen ZY
    World J Gastroenterol; 2016 Nov; 22(43):9571-9585. PubMed ID: 27920478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
    Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
    J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying patients at higher risk of hepatocellular carcinoma recurrence after liver transplantation in a multicenter cohort study from Argentina.
    Piñero F; Marciano S; Anders M; Orozco Ganem F; Zerega A; Cagliani J; Andriani O; de Santibañes E; Gil O; Podestá LG; McCormack L; Gadano A; Silva M
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):421-7. PubMed ID: 26684693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic role of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma undergoing liver transplantation.
    Zhang W; Kim R; Quintini C; Hashimoto K; Fujiki M; Diago T; Eghtesad B; Miller C; Fung J; Tan A; Menon KV; Aucejo F
    Liver Transpl; 2015 Jan; 21(1):101-11. PubMed ID: 25283528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidental Hepatocellular Carcinoma after Liver Transplantation: Clinicopathologic Features and Prognosis.
    Ozdemir F; Ince V; Usta S; Carr BI; Bag HG; Akatli AN; Kahraman AS; Yilmaz S
    Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation: retrospective analysis.
    Li HL; Ji WB; Zhao R; Duan WD; Chen YW; Wang XQ; Yu Q; Luo Y; Dong JH
    World J Gastroenterol; 2015 Mar; 21(12):3599-606. PubMed ID: 25834326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.
    Hanouneh IA; Macaron C; Lopez R; Aucejo F; Zein NN
    Transplant Proc; 2011 Dec; 43(10):3813-8. PubMed ID: 22172852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence of hepatocellular carcinoma after liver transplantation: Is there a place for resection?
    Fernandez-Sevilla E; Allard MA; Selten J; Golse N; Vibert E; Sa Cunha A; Cherqui D; Castaing D; Adam R
    Liver Transpl; 2017 Apr; 23(4):440-447. PubMed ID: 28187493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Living donor liver transplantation for hepatocellular carcinoma.
    Isik B; Ince V; Karabulut K; Kayaalp C; Yilmaz S
    Transplant Proc; 2012; 44(6):1713-6. PubMed ID: 22841251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is recurrence rate of incidental hepatocellular carcinoma after liver transplantation similar to previously known HCC? towards a predictive recurrence score.
    Piñero F; Mendizabal M; Casciato P; Galdame O; Quiros R; Bandi J; Mullen E; Andriani O; de Santibañes E; Podestá LG; Gadano A; Silva M
    Ann Hepatol; 2014; 13(2):211-8. PubMed ID: 24552863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multivariate analysis of recurrence of hepatocellular carcinoma after liver transplantation].
    Wu C; Shan H
    Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(29):2023-7. PubMed ID: 23253801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum C-reactive protein is a useful biomarker for predicting outcomes after liver transplantation in patients with hepatocellular carcinoma.
    An HJ; Jang JW; Bae SH; Choi JY; Yoon SK; Lee MA; You YK; Kim DG; Jung ES
    Liver Transpl; 2012 Dec; 18(12):1406-14. PubMed ID: 22821639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in patients with recurrent hepatocellular carcinoma treated with salvage liver transplantation: a single-center study.
    Wang P; Li H; Shi B; Que W; Wang C; Fan J; Peng Z; Zhong L
    Oncotarget; 2016 Jun; 7(23):35071-83. PubMed ID: 27145461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus-infected liver transplant recipients with incidental hepatocellular carcinoma: A prospective multicenter nationwide cohort study.
    Agüero F; Forner A; Valdivieso A; Blanes M; Barcena R; Manzardo C; Rafecas A; Castells L; Abradelo M; Barrera-Baena P; González-Diéguez L; Salcedo M; Serrano T; Jiménez-Pérez M; Herrero JI; Gastaca M; Aguilera V; Fabregat J; Del Campo S; Bilbao I; Romero CJ; Moreno A; Rimola A; Miro JM;
    Liver Transpl; 2017 May; 23(5):645-651. PubMed ID: 28188668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors for extrahepatic recurrence of hepatocellular carcinoma following liver transplantation.
    Andreou A; Bahra M; Schmelzle M; Öllinger R; Sucher R; Sauer IM; Guel-Klein S; Struecker B; Eurich D; Klein F; Pascher A; Pratschke J; Seehofer D
    Clin Transplant; 2016 Jul; 30(7):819-27. PubMed ID: 27107252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium.
    Agopian VG; Harlander-Locke MP; Ruiz RM; Klintmalm GB; Senguttuvan S; Florman SS; Haydel B; Hoteit M; Levine MH; Lee DD; Taner CB; Verna EC; Halazun KJ; Abdelmessih R; Tevar AD; Humar A; Aucejo F; Chapman WC; Vachharajani N; Nguyen MH; Melcher ML; Nydam TL; Mobley C; Ghobrial RM; Amundsen B; Markmann JF; Langnas AN; Carney CA; Berumen J; Hemming AW; Sudan DL; Hong JC; Kim J; Zimmerman MA; Rana A; Kueht ML; Jones CM; Fishbein TM; Busuttil RW
    Ann Surg; 2017 Sep; 266(3):525-535. PubMed ID: 28654545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.